Statistics
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
| Views | |
|---|---|
| A ... | 2032 |
Total Visits Per Month
| April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | |
|---|---|---|---|---|---|---|---|
| A ... | 40 | 18 | 106 | 98 | 90 | 32 | 36 |
File Visits
| Views | |
|---|---|
| 29FL5e9GFDkgQ.pdf | 768 |